Navigation Links
Thrombectomy in Medical News

Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group

WALTHAM, Mass., June 25 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over the next five years due to growing physician interest in treating deep...

ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark

- KENSEY NASH EARNS $1.5M MILESTONE UNDER SPECTRANETICS AGREEMENT - EXTON, Pa., June 23 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY ) today announced that the ThromCat (R) XT Thrombectomy Catheter System has been granted CE Marking approval which allows for the sale of...

MEDRAD(R) Revenues Grow 10 Percent in 2008

...ed Possis Medical in April 2008, pairing Possis' leadership position in the thrombectomy market with MEDRAD's cardiovascular products and worldwide infrastructure. ...arkets. The company's AngioJet(R) product is the world's leading mechanical thrombectomy system, with FDA approval to remove large and small clots from coronary art...

ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance

...n systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and i...nts 29,214 20,971 39% 107,146 86,035 25% thrombectomy and embolic protection 7,789 5,969 30% ...

ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009

...logies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net . ev3 and the ev3 logo are t...

Thrombectomy Device Market to Approach $300 Million by 2013, According to Millennium Research Group

... In the news release, thrombectomy Device Market to Approach $900 Million by 2013, Ac...ntence should read "...as a result, the mechanical thrombectomy market is expected to grow at a compound annual gr...2013." The complete, corrected release follows: thrombectomy Device Market to Approach $300 Million by 2013, Ac...

ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer

...ogies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net . ev3 and the ev3 l...

Thrombectomy Device Market to Approach $900 Million by 2013, According to Millennium Research Group

... and Thrombus Management Devices 2009 report, the thrombectomy device market, including both aspiration and mecha...f their synthetic material composition; mechanical thrombectomy is often performed in patients with AV access graf...chanical thrombectomy; as a result, the mechanical thrombectomy market is expected to grow at a compound annual gr...

ev3 Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference

...ogies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net . ev3 and the ev3 logo are t...

Innovative Deep Vein Thrombosis Treatment Yields Priceless Payoff

...oms such as chronic pain, swelling or even skin ulcerations that can lead to limb loss. A Pharmaceutical Vacuum Cleaner Possis' AngioJet Rheolytic thrombectomy System, which premiered in 1997, remains the medical world's leading mechanical clot-removing system. Think of it as a tiny, sensitive, sophisticated ...
Thrombectomy in Medical Technology

Unique Cardiovascular Treatment Readied for Global Market: Proprietary Paccocath(R) Technology is the Only Drug Eluting Balloon with Clinical Data

...n both Minneapolis, MN and Pittsburgh, PA, MEDRAD Interventional / Possis manufactures and markets segment-leading medical devices such as AngioJet(R) thrombectomy Systems, MEDRAD Avanta(R) Fluid Management Injector Systems, Mark V ProVis(R) Angiographic Contrast Injectors, the GuardDOG (R) Occlusion System, FETC...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

...logies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net . ev3, the ev3 logo, SilverHa...
Thrombectomy in Medical Products

XTD Hemodialysis Access Graft Thrombectomy Catheter

Description: The XTD Thrombectomy catheter is a mechanical catheter intended to percutaneously break-up and remove thrombus from occluded hemodialysis access grafts. The disposable catheter requires no external console and consists of a rotatable, spiral shaft which extends beyond the 6F plastic sheath as a fle...
Company:Xtrak Medical, Inc.

HYDROLYSER Thrombectomy Catheter 7F Dual Lumen

Description: HYDROLYSER Percutaneous Thrombectomy Catheter is a multi-lumen, over-the-wire thrombectomy catheter designed for rapid, effective and easy removal of fresh, soft thrombus in dialysis shunts. The HYDROLYSER provides an efficient, patient-friendly alternative to surgery and thrombolytic therapy. Co...
Company:Cordis Corporation

HYDROLYSER Thrombectomy Catheter 6F Triple Lumen

Description: HYDROLYSER Percutaneous Thrombectomy Catheter is a multi-lumen, over-the-wire thrombectomy catheter designed for rapid, effective and easy removal of fresh, soft thrombus in dialysis shunts. The HYDROLYSER catheter provides an efficient, patient-friendly alternative to surgery and thrombolytic ther...
Company:Cordis Corporation

AngioJet Thrombectomy system

Description: The AngioJet Thrombectomy system is the most advanced catheter-based thrombectomy system available today. The intricately designed components of the system are designed to offer safety, power, performance and versatility. The AngioJet System offers many advantages over alternative treatments; the m...
Company:Possis Medical, Inc.

ThromCat™ System

Description:... The ThromCat™ System is the first thrombectomy catheter to provide the right balance of strength and simplicity for the full range of thrombus removal procedures. With its unique Heliflex™ tec...
Company:Kensey Nash Corporation

AngioJet Spiroflex™ Catheter

Description:... Rapid exchange thrombectomy never handled like this before. Designed with tortuous anatomy in min...ility. Glide in with ease and track the twists and turns with the Spiroflex thrombectomy catheter....
Company:Possis Medical, Inc.

GORE-TEX® Stretch Vascular Grafts-Standard Wall with Removable Rings

Description:... the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and ensure utmost thrombectomy safety. The GORE-TEX® Stretch Vascular Graft, with published improved patency for dialysis access (10 papers 650 patients and 1 abstract), is ava...
Company:W. L. Gore & Associates, Inc.

GORE-TEX Stretch Vascular Grafts-Thin Wall

Description:... the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and ensure utmost thrombectomy safety. The GORE-TEX Stretch Vascular Graft, with published improved patency for dialysis access (10 papers 650 patients and 1 abstract), is availabl...
Company:W. L. Gore & Associates, Inc.

GORE-TEX Stretch Vascular Grafts-Standard Wall

Description:... the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and ensure utmost thrombectomy safety. The GORE-TEX Stretch Vascular Graft, with published improved patency for dialysis access (10 papers 650 patients and 1 abstract), is availabl...
Company:W. L. Gore & Associates, Inc.

GORE-TEX Bifurcated Stretch Vascular Grafts

Description:... the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and ensure utmost thrombectomy safety. The GORE-TEX Stretch Vascular Graft, with published improved patency for dialysis access (10 papers 650 patients and 1 abstract), is availabl...
Company:W. L. Gore & Associates, Inc.
Thrombectomy in Biological Technology

ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons

...ogies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net . ev3, the ev3 logo...

ev3 Inc. Appoints John L. Miclot to Board of Directors

...ogies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net . ev3 and the ev3 l...

ev3 Inc. Reports Third Quarter 2008 Financial Results

...n systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and it... Stents 26,772 23,105 16% 77,932 65,064 20% thrombectomy and embolic protection 6,938 5,368 29% 19,990 ...

ev3 Inc. to Report 2008 Second Quarter Financial Results and Host Conference Call on August 1, 2008

...ogies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net . ev3 and the ev3 logo are...

ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance

...007. Stent product sales increased 21% to $24.0 million from $19.8 million. thrombectomy and embolic protection product sales decreased slightly to $6.0 million fro... Stents 24,032 19,806 21% thrombectomy and embolic protection 5,955 6,218 -4% Procedural su...

Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement

...Possis Medical is a leading provider of mechanical thrombectomy devices used to treat narrowed or blocked arteries...ional markets. The combination of Possis Medical's thrombectomy platform and MEDRAD's vascular injection systems o...n 1997, Possis Medical's AngioJet(R) Rheolytic(TM) thrombectomy System remains the medical world's leading mechani...

TopSpin Medical Appoints Cindy Setum, Ph.D., Vice President Clinical Affairs

...esident of Clinical and Medical Affairs at Possis Medical, Inc., where for 12 years she supervised preclinical and clinical research in catheter-based thrombectomy (removal of intravascular blood clots). Yaron Tal, TopSpin's CEO, commented: "The addition of Dr. Setum to our management team as Vice President of C...

ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger

...sion System is a minimally invasive method of removing the obstructive plaque and restoring blood flow to the legs and feet. The company's Rinspirator thrombectomy system removes thrombus, or blood clots, from occluded arteries in patients suffering from PAD or coronary artery disease. Forward-Looking Statements...
Other Tags
(Date:2/28/2015)... 28, 2015 The MCA Youth Empowerment ... into one platform and gears towards the goal for ... series of group talks in smaller groups will be ... Education, Personal Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, ... of Malaysian youths. , Young adults aged ...
(Date:2/28/2015)... Heart diseases are on the rise ... urban adult population and 5 percent of rural adult ... 20-30 percent of them require specialized investigation and treatment ... vascular diseases (CVD). , A division of Indian Business ... report titled “Indian Coronary Stent Market Forecast to 2019”. ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to ... thinking. “The #1 block was lack of time ... Haman, who created the Thinkubator Innovation Studio in Chicago. ... they did not have enough time for innovative thinking ... innovation. , Solutionman’s monthly “Accelerating Innovation Training” workshops address ...
(Date:2/28/2015)... February 28, 2015 The Heart Fit ... a distributor of the machine. The Heart Fit Clinic ... license, like a franchise model. The goal is to ... reverse heart disease. To buy External Counterpulsation ... can help individuals through this process and achieve the ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 March—also ... good time to remind ourselves and others that ... say Atlantic NeuroSurgical Specialists (ANS). , Concussions are ... account for 75% of TBIs. There are 1.6-3.8 ... may sound benign, but it is a brain ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
(Date:2/10/2015)... Inc. (NYSE: ALR), a global leader in rapid ... ended December 31, 2014. Namal Nawana, ... "We made substantial progress in the fourth quarter ... rapid diagnostics and delivering against our financial plans.  ... January enabled us to substantially reduce our debt, ...
(Date:2/5/2015)... Jan. 26, 2015   Epic Sciences , a precision ... announced that Murali Prahalad , Ph.D., president and CEO, ... Conference (PMWC) 2015: Silicon Valley, which is taking place ... Calif. on January 26-28, 2015. ... Age as Biomarkers." Last year, Epic Sciences was a finalist ...
(Date:2/5/2015)... , Jan. 28, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... the upcoming RedChip Global Online CEO Conference on January ... Gino Pereira , CEO of NXT-ID will ... lead product, the Wocket smart wallet and its full ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
Other Contents